Services to examine them and mena signatures within a case-control study of patients with ER-positive breast cancer

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600762P
Awardee
Awarding agency
Obligated
$46,600

Award facts

Opportunity
Contract value 100% obligated
$46,600.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · DE-obligation of funds from FY2016 expiring lines. -$1,400
Original award $48,000

About this award

The National Cancer Institute awarded a purchase order to Metastat, Inc. for $46,600 on September 21, 2016. The order covers services to examine and analyze MENA signatures within a case-control study of patients with ER-positive breast cancer. Work is performed in Rockville, Maryland. The ultimate completion date is March 25, 2021. This purchase order represents a de-obligation of funds from FY2016 expiring lines.

Quick answers

Who was awarded contract HHSN261201600762P?

HHSN261201600762P was awarded to Metastat, Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2016.

How much is contract HHSN261201600762P worth?

The government has obligated $46,600 on HHSN261201600762P.

Was contract HHSN261201600762P competed?

The extent of competition for HHSN261201600762P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award